Immunology Fall 2026: Lecture 4 Humoral Innate Immunity

Overview

Brianne Barker explains how preformed humoral innate defenses act immediately against extracellular microbes, first through antimicrobial peptides such as lysozyme, defensins, alpha-2-macroglobulin, and lactoferrin. She then traces complement from its three initiation pathways—the antibody-dependent classical pathway, mannose-binding lectin pathway, and spontaneously activated alternative pathway—through C3 and C5 cleavage to membrane attack, inflammation, and opsonization, emphasizing amplification and host-cell inhibition.

Key takeaways

Preformed humoral innate proteins can act immediately after microbial entry, sometimes eliminating an extracellular infection before symptoms appear.
Lysozyme achieves self–non-self discrimination by cleaving peptidoglycan, a bacterial cell-wall component absent from human cells.
Complement has three initiation routes—classical, lectin, and alternative—that converge on C3 and can produce membrane attack, inflammation, and opsonization.
C3b both marks microbes for uptake through phagocyte complement receptors and helps drive C5 cleavage toward formation of the C5b–C9 membrane attack complex.
The alternative pathway’s spontaneous C3 tickover enables rapid surface tagging and amplification, but host-cell complement inhibitors are essential to prevent self-damage.

Chapters

0:00 Preformed Humoral Defenses Act Before Innate Immune Cells

Humoral innate immunity refers here to proteins already present before infection, ready to act from the first seconds after a microbe enters.
These proteins are especially useful against extracellular pathogens and can sometimes clear an infection before symptoms develop.
Barker contrasts their immediate action with innate immune cells, which may take hours to days to become ready.

4:00 Antimicrobial Peptides Concentrate at Barrier Organs

Antimicrobial peptides block microbial activity and are produced at high levels in barrier organs such as the skin and intestine.
Their locations vary: some occur in saliva, respiratory secretions, or other barrier-associated fluids.
Barker notes that antimicrobial peptides are major defenses in some non-vertebrate organisms and mentions a frog-skin peptide studied against influenza.

7:25 Lysozyme Breaks a Bacteria-Specific Cell-Wall Bond

Lysozyme is an enzyme that cleaves the beta-1,4 glycosidic linkage in peptidoglycan, a key component of bacterial cell walls.
Because human cells lack peptidoglycan, lysozyme illustrates how an immune defense can target microbes without attacking host cells.
The enzyme acts on a conserved bacterial feature rather than distinguishing among particular species such as E. coli and Staphylococcus.

10:25 Defensins Disrupt Microbial Membranes Without Targeting Host Cells

Alpha- and beta-defensins are antimicrobial peptides found especially in barrier tissues; intestinal Paneth cells produce defensins in small crypts.
Many defensins are constitutive, meaning they are made continuously and are available before infection.
Positively charged defensins can form pores in bacterial membranes; differences in membrane charge organization help limit damage to human cells.

15:00 Alpha-2-Macroglobulin and Lactoferrin Block Microbial Growth

Alpha-2-macroglobulin traps certain microbial proteases: binding to a protease target sequence triggers a conformational change that inactivates the enzyme.
This strategy can limit disease-causing damage without directly killing the microbe.
Lactoferrin binds iron, restricting access to an essential nutrient and contributing to the host–microbe competition known as iron piracy.
Researchers are exploring antimicrobial peptides as possible treatments, while considering resistance and other trade-offs.

22:00 Complement: Three Initiation Routes Converge on Shared Effects

Complement, sometimes abbreviated C′, is a group of proteins historically named for their ability to complement antibody activity.
Complement proteins are commonly activated by proteolytic cleavage into fragments, often labeled with lowercase a and b.
The system has three initiation pathways that converge around C3, followed by effector functions that act against microbes.
A convertase is the protease complex that cleaves a named complement protein, such as the C3 convertase.

30:39 Antibody Binding Starts the Classical Complement Pathway

The classical pathway begins when antibodies bind microbial surfaces and present their tails in a geometry that allows C1 to attach.
Antibody dependence links this complement route to adaptive immunity; organisms without antibodies cannot initiate the classical pathway.
Antibody-bound C1 undergoes a conformational change and becomes an active protease.

37:00 C4 and C2 Form the Classical C3 Convertase

Activated C1 cleaves C4 and C2; larger fragments become associated with the microbial surface while smaller fragments disperse.
Surface-associated C4 and C2 form the classical-pathway C3 convertase, which cleaves C3 into C3a and C3b.
C3 is the central convergence point: different complement initiation pathways can each generate a C3 convertase.

43:00 C3b Leads to C5 Cleavage and the Membrane Attack Complex

C3b participates in the C5 convertase, which cleaves C5 into C5a and C5b.
C5b recruits C6, C7, C8, and multiple C9 molecules to build the membrane attack complex, or MAC.
The C5b–C9 complex forms pores in microbial membranes; many pores can result from a small initial complement trigger.

48:00 C3a and C5a Recruit Cells and Promote Inflammation

C3a and C5a bind their respective receptors and trigger inflammatory signaling.
Their effects include increased blood-vessel permeability, vessel dilation, and recruitment or activation of innate immune cells.
C3a and C5a were historically called anaphylatoxins because they can contribute to anaphylactic shock.

51:00 C3b Opsonization Marks Microbes for Phagocytosis

Opsonization means coating a target so that it is more likely to be phagocytosed; C3b on a microbe serves as an opsonin.
Phagocytic cells use complement receptors to recognize the C3b coating and take up the marked microbe.
Complement receptors can also help enhance adaptive immune responses, connecting innate recognition with later immunity.

58:00 Mannose-Binding Lectin Starts the Lectin Pathway

A lectin is a protein that binds carbohydrates; mannose-binding lectin (MBL) recognizes mannose sugars commonly found on microbial surfaces.
MBL resembles C1 and, after binding microbial mannose, activates C4 and C2 to form the same C3 convertase used by the classical pathway.
The MBL pathway can operate before antibodies are available, while the classical and lectin pathways can both function when their conditions are met.

1:06:20 C3 Tickover Launches the Alternative Pathway

C3 contains a strained thioester bond and can spontaneously cleave without a protease, a process called complement tickover.
The exposed reactive group can bind water or form a covalent bond with suitable groups on nearby microbial surfaces.
Factor B, factor D, and properdin participate in the alternative pathway, which can begin without antibodies or MBL.

1:13:25 Alternative-Pathway Amplification Multiplies C3 Activation

C3 deposited through another pathway can feed into the alternative pathway, generating additional C3 activation and amplifying the response.
This amplification helps explain how a limited initial trigger can lead to extensive complement deposition and many MAC pores.
The alternative pathway is widespread across animal groups and contributes to rapid innate defense.

1:14:56 Complement Inhibitors Protect Host Cells from Self-Attack

Spontaneous C3 activation can also encounter host-cell surfaces, creating a risk of complement damage to the body’s own cells.
Host cells express complement inhibitors that remove or suppress complement activity across multiple stages; microbes may lack equivalent protection.
Continuous regulation trades efficiency for speed, and complement that escapes control can contribute to disorders such as arthritis.

Summary, takeaways, and chapters were generated by AI from the video's transcript and may contain errors. The video belongs to its creator, Brianne Barker.